Emerging Treatments and Clinical Challenges in Myelodysplastic Syndromes: ASCO 2021 and EHA 2021 Updates

home / publications / supplements / myelodysplastic-syndromes-asco-2021-and-eha-2021-updates

This publication features research that was presented in myelodysplastic syndromes from the 2021 ASCO Annual Meeting and 2021 EHA Congress, including expert perspectives on how the data have clinical implications.

Sponsored by Takeda Oncology/Content Developed Independently by OncLive